1. Home
  2. BDMD vs HQL Comparison

BDMD vs HQL Comparison

Compare BDMD & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDMD
  • HQL
  • Stock Information
  • Founded
  • BDMD 2012
  • HQL 1992
  • Country
  • BDMD China
  • HQL United States
  • Employees
  • BDMD N/A
  • HQL N/A
  • Industry
  • BDMD
  • HQL Investment Managers
  • Sector
  • BDMD
  • HQL Finance
  • Exchange
  • BDMD NYSE
  • HQL Nasdaq
  • Market Cap
  • BDMD 317.0M
  • HQL 372.7M
  • IPO Year
  • BDMD N/A
  • HQL N/A
  • Fundamental
  • Price
  • BDMD $8.85
  • HQL $13.49
  • Analyst Decision
  • BDMD
  • HQL
  • Analyst Count
  • BDMD 0
  • HQL 0
  • Target Price
  • BDMD N/A
  • HQL N/A
  • AVG Volume (30 Days)
  • BDMD 6.1M
  • HQL 120.9K
  • Earning Date
  • BDMD 01-01-0001
  • HQL 01-01-0001
  • Dividend Yield
  • BDMD N/A
  • HQL 11.56%
  • EPS Growth
  • BDMD 578.78
  • HQL N/A
  • EPS
  • BDMD 0.43
  • HQL 0.79
  • Revenue
  • BDMD $33,048,249.00
  • HQL N/A
  • Revenue This Year
  • BDMD N/A
  • HQL N/A
  • Revenue Next Year
  • BDMD N/A
  • HQL N/A
  • P/E Ratio
  • BDMD $20.75
  • HQL $17.08
  • Revenue Growth
  • BDMD N/A
  • HQL N/A
  • 52 Week Low
  • BDMD $1.05
  • HQL $11.34
  • 52 Week High
  • BDMD $13.52
  • HQL $14.37
  • Technical
  • Relative Strength Index (RSI)
  • BDMD N/A
  • HQL 46.35
  • Support Level
  • BDMD N/A
  • HQL $13.14
  • Resistance Level
  • BDMD N/A
  • HQL $13.68
  • Average True Range (ATR)
  • BDMD 0.00
  • HQL 0.25
  • MACD
  • BDMD 0.00
  • HQL 0.05
  • Stochastic Oscillator
  • BDMD 0.00
  • HQL 70.48

About BDMD BAIRD MEDICAL INVESTMENT HLDGS LTD

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.

About HQL abrdn Life Sciences Investors Shares of Beneficial Interest

abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.

Share on Social Networks: